Neogen (NEOG) Competitors

Haemonetics (NYSE:HAE) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Is HAE or NEOG more profitable?

Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	12.32%	26.37%	9.22%
Neogen	-53.56%	2.69%	1.82%

Which has better valuation & earnings, HAE or NEOG?

Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.36B	2.56	$167.68M	$3.31	21.92
Neogen	$924.22M	1.11	-$9.42M	-$2.23	-2.13

Which has more risk & volatility, HAE or NEOG?

Haemonetics has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500.

Do analysts recommend HAE or NEOG?

Haemonetics currently has a consensus target price of $97.30, suggesting a potential upside of 34.11%. Neogen has a consensus target price of $7.50, suggesting a potential upside of 58.23%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	3.00
Neogen	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media refer more to HAE or NEOG?

In the previous week, Neogen had 11 more articles in the media than Haemonetics. MarketBeat recorded 26 mentions for Neogen and 15 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.43 beat Neogen's score of 0.32 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Neogen	7 Very Positive mention(s)	0 Positive mention(s)	13 Neutral mention(s)	6 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals have more ownership in HAE or NEOG?

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 1.8% of Haemonetics shares are held by insiders. Comparatively, 1.1% of Neogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Haemonetics beats Neogen on 14 of the 17 factors compared between the two stocks.